- Home
- APLT vs FOXX Comparison
APLT vs FOXX Comparison
Compare APLT & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- FOXX
- Stock Information
- Founded
- APLT 2016
- FOXX 2017
- Country
- APLT United States
- FOXX United States
- Employees
- APLT N/A
- FOXX N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- FOXX
- Sector
- APLT Health Care
- FOXX
- Exchange
- APLT Nasdaq
- FOXX Nasdaq
- Market Cap
- APLT 37.5M
- FOXX 33.5M
- IPO Year
- APLT 2019
- FOXX N/A
- Fundamental
- Price
- APLT $0.40
- FOXX $5.73
- Analyst Decision
- APLT Buy
- FOXX
- Analyst Count
- APLT 7
- FOXX 0
- Target Price
- APLT $6.10
- FOXX N/A
- AVG Volume (30 Days)
- APLT 1.9M
- FOXX 8.0K
- Earning Date
- APLT 05-20-2025
- FOXX 05-19-2025
- Dividend Yield
- APLT N/A
- FOXX N/A
- EPS Growth
- APLT N/A
- FOXX N/A
- EPS
- APLT N/A
- FOXX N/A
- Revenue
- APLT $455,000.00
- FOXX $42,988,015.00
- Revenue This Year
- APLT $1,768.13
- FOXX N/A
- Revenue Next Year
- APLT $361.28
- FOXX N/A
- P/E Ratio
- APLT N/A
- FOXX N/A
- Revenue Growth
- APLT N/A
- FOXX 98.81
- 52 Week Low
- APLT $0.30
- FOXX $2.45
- 52 Week High
- APLT $10.62
- FOXX $14.99
- Technical
- Relative Strength Index (RSI)
- APLT 46.92
- FOXX N/A
- Support Level
- APLT $0.39
- FOXX N/A
- Resistance Level
- APLT $0.44
- FOXX N/A
- Average True Range (ATR)
- APLT 0.04
- FOXX 0.00
- MACD
- APLT 0.01
- FOXX 0.00
- Stochastic Oscillator
- APLT 45.49
- FOXX 0.00
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About FOXX Foxx Development Holdings Inc. Common Stock
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.